Amini Arya, DeWitt Peter E, Vinogradskiy Yevgeniy, Rusthoven Chad G, Altunbas Cem, Schefter Tracey E, Fisher Christine M
Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, United States.
Department of Biostatistics and Informatics, University of Colorado Denver, Aurora, CO, United States.
Rep Pract Oncol Radiother. 2016 May-Jun;21(3):195-200. doi: 10.1016/j.rpor.2016.02.003. Epub 2016 Mar 2.
A single-institution review assessing patient characteristics contributing to daily organ motion in postoperative endometrial and cervical cancer patients treated with intensity-modulated radiotherapy (IMRT).
The Radiation Therapy Oncology Group has established consensus guidelines for postoperative pelvic IMRT, recommending a 7 mm margin on all three axes of the target volume.
Daily shifts on 457 radiation setups for 18 patients were recorded in the x axis (lateral), y axis (superior-inferior) and z axis (anterior-posterior); daily positions of the planning tumor volume were referenced with the initial planning scan to quantify variations.
Of the 457 sessions, 85 (18.6%) had plan shifts of at least 7 mm in one of the three dimensions. For obese patients (body mass index [BMI] ≥ 30), 75/306 (24.5%) sessions had plan shifts ≥7 mm. Odds of having a shift ≥7 mm in any direction was greater for obese patients under both univariate (OR 4.227, 95% CI 1.235-14.466, p = 0.021) and multivariate (OR 5.000, 95% CI 1.341-18.646, p = 0.016) analyses (MVA). Under MVA, having a BMI ≥ 30 was associated with increased odds of shifts in the anterior-posterior (1.173 mm, 95% CI 0.281-2.065, p = 0.001) and lateral (2.074 mm, 95% CI 1.284-2.864, p < 0.000) directions but not in the superior-inferior axis (0.298 mm, 95% CI -0.880 to 1.475, p = 0.619) exceeding 7 mm.
Based on these findings, the standard planned tumor volume expansion of 7 mm is less likely to account for daily treatment changes in obese patients.
一项单机构回顾性研究,评估接受调强放射治疗(IMRT)的子宫内膜癌和宫颈癌术后患者日常器官运动的相关患者特征。
放射肿瘤学组已制定术后盆腔IMRT的共识指南,建议在靶区体积的三个轴向上均设置7毫米的边界。
记录了18例患者457次放疗设置在x轴(横向)、y轴(上下)和z轴(前后)的每日位移;将计划靶区体积的每日位置与初始计划扫描进行比对,以量化变化。
在457次治疗中,85次(18.6%)在三个维度中的一个维度上计划位移至少7毫米。对于肥胖患者(体重指数[BMI]≥30),75/306次(24.5%)治疗的计划位移≥7毫米。在单因素(OR 4.227,95%CI 1.235 - 14.466,p = 0.021)和多因素(OR 5.000,95%CI 1.341 - 18.646,p = 0.016)分析(MVA)中,肥胖患者在任何方向上发生≥7毫米位移的几率都更高。在多因素分析下,BMI≥30与前后方向(1.173毫米,95%CI 0.281 - 2.065,p = 0.001)和横向(2.074毫米,95%CI 1.284 - 2.864,p < 0.000)方向上位移增加的几率相关,但与上下轴方向(0.298毫米,95%CI -0.880至1.475,p = 0.619)超过7毫米的位移无关。
基于这些发现,标准计划靶区体积扩大7毫米不太可能解释肥胖患者的日常治疗变化。